Recent clinical trial data have suggested that low cholesterol might cause
increased mortality from noncardiovascular conditions. Several randomized t
rials have suggested an increase in noncoronary deaths at low levels of tot
al cholesterol, When subcategories for causes of death were investigated, i
t was noted that hemorrhagic stroke risk was inversely related to total cho
lesterol, whereas nonhemorrhagic stroke risk was positively related to tota
l cholesterol. Certain cancers were shown to be more common at low total ch
olesterol levels, namely lung, liver, lymphatic, and hematopoietic cancer.
Another issue to consider is whether increased mortality rates are seen in
individuals with "naturally" occurring low cholesterol or whether they are
seen in individuals whose cholesterol has been deliberately lowered through
dietary or drug intervention, or in both, If an association between low ch
olesterol and noncardiovascular mortality is present, there is continuing u
ncertainty regarding the mechanism by which it occurs.